dsip plasma half-life Half Life - an overview Terminal half-life and accumulation of

Weight loss trajectory was still accelerating Phase 1 (oral): 10.4-13.1% weight loss at 12 weeks depending on dosing regimen vs 1.2% placebo Phase 2 (T2D): SC amycretin showed up to 14.5% weight loss and HbA1c reductions up to 1.8% at 36 weeks

Individuals with MTHFR variants may rely more heavily on active B12 forms like methylcobalamin or adenosylcobalamin, depending on methylation response

Herman WH, Kennedy L

Selection of Delivery System Type Drug delivery systems can be classified into physical, chemical and biological delivery systems

Structural basis of presequence recognition by the mitochondrial protein import receptor Tom20

Following these guidelines ensures Vitamin B12 injections are safe and effective